LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 80.12 | 21.74 | 3295 | 6211 | 0.5304 | 0.8505 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 80.12 | 21.74 | 3319 | 6211 | 0.5343 | 0.8521 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 80.12 | 21.74 | 316 | 6211 | 0.0509 | 0.3883 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 80.12 | 21.74 | 3232 | 6211 | 0.5203 | 0.8461 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.09 | 21.74 | 3492 | 6201 | 0.5631 | 0.8640 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.09 | 21.74 | 3510 | 6201 | 0.5660 | 0.8652 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.09 | 21.74 | 278 | 6201 | 0.0448 | 0.3668 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.09 | 21.74 | 3369 | 6201 | 0.5433 | 0.8558 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.06 | 21.74 | 3606 | 6152 | 0.5861 | 0.8730 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.06 | 21.74 | 3626 | 6152 | 0.5894 | 0.8743 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.06 | 21.74 | 346 | 6152 | 0.0562 | 0.4046 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.06 | 21.74 | 3469 | 6152 | 0.5639 | 0.8641 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.03 | 21.74 | 3766 | 6155 | 0.6118 | 0.8829 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.03 | 21.74 | 3784 | 6155 | 0.6148 | 0.8840 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.03 | 21.74 | 316 | 6155 | 0.0513 | 0.3890 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.03 | 21.74 | 3601 | 6155 | 0.5850 | 0.8726 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 88.00 | 21.74 | 3858 | 6081 | 0.6344 | 0.8911 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 88.00 | 21.74 | 3879 | 6081 | 0.6378 | 0.8924 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 88.00 | 21.74 | 318 | 6081 | 0.0523 | 0.3911 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 88.00 | 21.74 | 3719 | 6081 | 0.6115 | 0.8826 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.97 | 21.74 | 4061 | 6084 | 0.6674 | 0.9030 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.97 | 21.74 | 4078 | 6084 | 0.6702 | 0.9039 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.97 | 21.74 | 352 | 6084 | 0.0579 | 0.4085 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.97 | 21.74 | 3840 | 6084 | 0.6311 | 0.8899 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 91.94 | 21.74 | 4242 | 6121 | 0.6929 | 0.9118 | MN20160310_N01 | H06 |